Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis

Author： Li Yuqin  

Publisher： Springer Publishing Company

ISSN： 0043-5325

Source： Wiener klinische Wochenschrift, Vol.122, Iss.13-14, 2010-07, pp. : 413-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 768-775

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ten‐day triple therapy versus sequential therapy versus concomitant therapy as first‐line treatment for Helicobacter pylori infection

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1134-1139

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sequential vs. prolonged 14‐day triple therapy for Helicobacter pylori eradication: the meta‐analysis may be influenced by ‘geographical weighting’

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 1368-5031, Iss. 10, 2015-10 ,pp. : 1112-1120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sequential vs. prolonged 14‐day triple therapy for Helicobacter pylori eradication: the meta‐analysis may be influenced by ‘geographical weighting’

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 10, 2015-10 ,pp. : 1112-1120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fluoroquinolone Sequential Therapy for Helicobacter pylori: A Meta‐analysis

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 8, 2015-08 ,pp. : 719-730

John Wiley & Sons Inc

Access to resources Recommend Favorite